Vanguard Personalized Indexing Management, LLC Bicycle Therapeutics PLC Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 12,953 shares of BCYC stock, worth $83,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,953Holding current value
$83,417% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
115Shares Held
40.4MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$70.1 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$22.2 Million6.5% of portfolio
-
Armistice Capital, LLC New York, NY2.8MShares$18 Million0.34% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$17.1 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$13 Million0.72% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $191M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...